Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université de Montréal

$75,000.00

Bioorganic chemistry of transpeptidases

FY 2009-10

Summary
Transglutaminases (TGases) are calcium-dependent enzymes that catalyse the formation of cross-links between proteins. TGases play vital physiological roles such as the stabilization of blood clots and the extracellular matrix in tissues. They have also been implicated in several disorders including the deposition of plaques associated with neurodegenerative diseases (Alzheimer's, Huntington's and Parkinson's diseases), cancer metastasis and Celiac disease. Past work in the Keillor group on the mechanism of action of TGases has laid the groundwork for the research to be carried out over the next granting period: 1) TGase mechanistic studies: The acceptor substrate binding site will be located and the conformational equilibrium will be studied. 2) TGase inhibition studies: New series of inhibitors will be prepared and evaluated in our group, in the design of high affinity ligands as therapeutic lead compounds. 3) TGase chemical biology: Fluorescent probes designed to identify and localize TGases and their native protein substrates will be prepared and evaluated in vitro and in cell culture. 4) TGase engineering: The transamidase activity of TGase is unique and will be tailored by directed evolution toward two specific applications - the site-specific labelling of proteins with fluorophores and with sugars. The bioorganic chemistry in this proposal embodies a highly developed combination of enzymology, synthetic and physical organic chemistry, biochemistry and cell biology. The short-term results will represent important contributions to understanding enzyme structure-function relationships and biocatalysis. The long-term results deriving from the application of this understanding will include the development of useful inhibitor drugs and the design of novel biocatalysts for practical application.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
184034-2009
Name nom
Keillor, Jeffrey
Department département
Chimie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2009
Award amount
75000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3705
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Bio-organic chemistry
Research subject fr
Chimie bio-organique
Partie
1
Nb partie
5
Application title
Bioorganic chemistry of transpeptidases
Keyword
NA
Application summary
Transglutaminases (TGases) are calcium-dependent enzymes that catalyse the formation of cross-links between proteins. TGases play vital physiological roles such as the stabilization of blood clots and the extracellular matrix in tissues. They have also been implicated in several disorders including the deposition of plaques associated with neurodegenerative diseases (Alzheimer's, Huntington's and Parkinson's diseases), cancer metastasis and Celiac disease. Past work in the Keillor group on the mechanism of action of TGases has laid the groundwork for the research to be carried out over the next granting period: 1) TGase mechanistic studies: The acceptor substrate binding site will be located and the conformational equilibrium will be studied. 2) TGase inhibition studies: New series of inhibitors will be prepared and evaluated in our group, in the design of high affinity ligands as therapeutic lead compounds. 3) TGase chemical biology: Fluorescent probes designed to identify and localize TGases and their native protein substrates will be prepared and evaluated in vitro and in cell culture. 4) TGase engineering: The transamidase activity of TGase is unique and will be tailored by directed evolution toward two specific applications - the site-specific labelling of proteins with fluorophores and with sugars. The bioorganic chemistry in this proposal embodies a highly developed combination of enzymology, synthetic and physical organic chemistry, biochemistry and cell biology. The short-term results will represent important contributions to understanding enzyme structure-function relationships and biocatalysis. The long-term results deriving from the application of this understanding will include the development of useful inhibitor drugs and the design of novel biocatalysts for practical application.
Université de Montréal - $75,000 Grant (2009-10) | Canada Spends